Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
36.71
-0.44 (-1.18%)
At close: Nov 17, 2026, 4:00 PM EST
36.07
-0.64 (-1.74%)
After-hours: Nov 17, 2026, 7:40 PM EST
Progyny Revenue
Progyny had revenue of $341.25M in the quarter ending September 30, 2026, with 8.91% growth. This brings the company's total for the last twelve months to $1.34B, up 5.52% year-over-year. In the year 2025, Progyny had annual revenue of $1.29B with 10.40% growth. That makes Progyny the 6,442nd largest company in the world by revenue and 1,600th in the United States.
Revenue (ttm)
$1.34B
Revenue Growth
+5.52%
P/S Ratio
2.02
Revenue / Employee
$1,563,869
Employees
856
Market Cap
2.70B
Revenue by Segment
- Fertility Benefit Services 830.93M 64.5%
- Pharmacy Benefit Services 457.73M 35.5%
Fiscal year ended Dec 31, 2025 See the full Progyny breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.29B | 121.44M | 10.40% |
| Dec 31, 2024 | 1.17B | 78.62M | 7.22% |
| Dec 31, 2023 | 1.09B | 301.69M | 38.34% |
| Dec 31, 2022 | 786.91M | 286.29M | 57.19% |
| Dec 31, 2021 | 500.62M | 155.76M | 45.17% |
| Dec 31, 2020 | 344.86M | 115.18M | 50.15% |
| Dec 31, 2019 | 229.68M | 124.28M | 117.92% |
| Dec 31, 2018 | 105.40M | 56.82M | 116.94% |
| Dec 31, 2017 | 48.58M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 450.06B |
| CVS Health | 418.16B |
| The Cigna Group | 286.32B |
| Elevance Health | 201.83B |
| Centene | 180.41B |
| Humana | 154.19B |
| Molina Healthcare | 42.08B |
| Oscar Health | 17.47B |
PGNY News
- 12 hours ago - Progyny price target raised to $42 from $36 at Truist - TheFly
- 1 day ago - Progyny price target raised to $42 from $36 at Truist - TheFly
- 6 days ago - Progyny price target raised to $37 from $30 at Barclays - TheFly
- 8 days ago - Progyny price target raised to $35 from $30 at JPMorgan - TheFly
- 12 days ago - Progyny price target raised to $36 from $31 at BofA - TheFly
- 12 days ago - Progyny price target raised to $35 from $31 at Cantor Fitzgerald - TheFly
- 12 days ago - Progyny price target raised to $36 from $35 at Canaccord - TheFly
- 12 days ago - Progyny price target raised to $38 from $37 at Wells Fargo - TheFly